Page last updated: 2024-11-08

littorine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

littorine: RN given refers to (3(R)-endo)-isomer; RN for cpd without isomeric designation not avail 3/90; isolated from a Duboisia hybrid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
DuboisiagenusA plant genus of the family SOLANACEAE that is a source of SCOPOLAMINE and other TROPANES.[MeSH]SolanaceaeA plant family of the order SOLANALES, class MAGNOLIOPSIDA. Among the most noted are POTATOES; TOMATOES; CAPSICUM (green and red peppers); TOBACCO; and BELLADONNA.[MeSH]

Cross-References

ID SourceID
PubMed CID443005
CHEBI ID6506
SCHEMBL ID24475294
MeSH IDM0174461

Synonyms (7)

Synonym
littorine
(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) (2r)-2-hydroxy-3-phenylpropanoate
CHEBI:6506
8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate
DTXSID20944553
Q6653346
SCHEMBL24475294

Research Excerpts

Overview

Littorine is a key biosynthetic intermediate in the hyoscyamine and scopolamine biosynthesis pathways.

ExcerptReferenceRelevance
"Littorine is a key biosynthetic intermediate in the hyoscyamine and scopolamine biosynthetic pathways."( Functional genomics analysis reveals two novel genes required for littorine biosynthesis.
Chen, M; Huang, JP; Huang, SX; Kai, G; Lan, X; Liao, Z; Qiu, F; Wang, J; Yang, C; Zeng, J; Zhou, W, 2020
)
1.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tropane alkaloid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
superpathway of hyoscyamine and scopolamine biosynthesis434
hyoscyamine and scopolamine biosynthesis422
tropane alkaloids biosynthesis028
superpathway of hyoscyamine (atropine) and scopolamine biosynthesis039

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's1 (6.67)18.2507
2000's9 (60.00)29.6817
2010's2 (13.33)24.3611
2020's2 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.89 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index59.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]